Evonetix Announces Agreement for Revolutionary Gene Synthesis Platform With Analog Devices

EVONETIX LTD (‘Evonetix’), the company developing semiconductor scale technology to improve access to gene synthesis, today announces the signing of a joint development agreement and commercial supply agreement with Analog Devices, Inc. (ADI), a global semiconductor leader.

New AI tool can help select the most suitable treatment for cancer patients

A new artificial intelligence (AI) tool that can help to select the most suitable treatment for cancer patients has been developed by researchers at The

July 3, 2024

ProductLife enhances drug development with IntiQuan acquisition

IntiQuan enhances PLG’s portfolio with advanced dose-response evaluations and proactive safety assessments. Credit: IM Imagery/Shutterstock. ProductLife Group (PLG) has announced the acquisition of IntiQuan, a

October 7, 2024

Study: Medicaid waivers have limited impact on opioid overdose crisis

For generations, the federal government has largely refrained from paying for mental health and substance use treatment in large residential facilities.

November 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.